What Are the Fundamentals Of WBA?

By Kim Brooks • Wednesday, April 05 09:41 • Permanent Link

Large-cap Consumer Staples company Walgreens Boots Alliance has moved 0.1% so far today on a volume of 220,634, compared to its average of 6,874,872. In contrast, the S&P 500 index moved -0.0%.

Walgreens Boots Alliance trades -11.45% away from its average analyst target price of $40.51 per share. The 14 analysts following the stock have set target prices ranging from $35.0 to $54.0, and on average have given Walgreens Boots Alliance a rating of hold.

If you are considering an investment in WBA, you'll want to know the following:

Walgreens Boots Alliance's current price is 50.4% above its Graham number of $23.86, which implies that at its current valuation it does not offer a margin of safety
Walgreens Boots Alliance has moved -19.1% over the last year, and the S&P 500 logged a change of -8.5%
Based on its trailing earnings per share of -3.64, Walgreens Boots Alliance has a trailing 12 month Price to Earnings (P/E) ratio of -9.9 while the S&P 500 average is 15.97
WBA has a forward P/E ratio of 7.5 based on its forward 12 month price to earnings (EPS) of $4.81 per share
The company has a price to earnings growth (PEG) ratio of 3.79 — a number near or below 1 signifying that Walgreens Boots Alliance is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 1.5 compared to its sector average of 4.29
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company.
Based in Deerfield, the company has 200,000 full time employees and a market cap of $30,951,428,096. Walgreens Boots Alliance currently returns an annual dividend yield of 5.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.